Stock PSTX POSEIDA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
3.06 USD +3.03% Intraday chart for Poseida Therapeutics, Inc. -11.56% -8.93%
May. 14 Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises MT
May. 14 Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
POSEIDA THERAPEUTICS, INC. Stock Poseida Therapeutics, Inc.
 297M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. PSTX Stock
  4. Charts Poseida Therapeutics, Inc.
  5. Sector Chart